Effects of Exercise and Virtual Reality on Depression

Sponsor
The University of Texas at Arlington (Other)
Overall Status
Recruiting
CT.gov ID
NCT05973461
Collaborator
(none)
100
1
2
27.5
3.6

Study Details

Study Description

Brief Summary

This study is evaluating the effects of riding on a cycle ergometer while experiencing virtual reality to determine its effect on mood.

Condition or Disease Intervention/Treatment Phase
  • Device: Exercise and virtual reality
  • Other: Riding a cycle ergometer
N/A

Detailed Description

Adults (males and females) above the age of 18 yrs will be recruited to determine if they have symptoms of depression based on a questionnaire (Center for Epidemiologic Studies - Depression Scale (CES-D). They will then complete a Beck Inventory before and after the exercise. Participants will be divided into groups either having symptoms of depression or not. They will be randomized to ride on a cycle ergometer with or without using Virtual Reality (VR) that will allow them to view neighborhoods or parks during the exercise. The ergometer will be set at resistance raising the heart rate to 65% of their age-predicted heart rate maximum. They will ride for 20 min and then complete the Beck Inventory to determine any changes in their depressive symptoms.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
males and females, with and without symptoms of depressionmales and females, with and without symptoms of depression
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Effects of Exercise With Virtual Reality on Females and Males With or Without Depression
Actual Study Start Date :
May 17, 2022
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Aug 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cycle Ergometer and Virtual Reality

30 min ride on cycle ergometer while viewing neighborhood scenes using virtual reality

Device: Exercise and virtual reality
Riding a cycle ergometer while experiencing virtual reality

Experimental: Cycle Ergometer

30 min ride on cycle ergometer

Other: Riding a cycle ergometer
Riding on a cycle ergometer without experiencing virtual reality

Outcome Measures

Primary Outcome Measures

  1. Beck Depression Inventory Scale of Measurement [5 minutes]

    Assessment of symptoms of depression pre and post-intervention cycle exercise. The Beck Depression Inventory is a 21-item, multiple-choice, self-report survey that measures characteristic attitudes and symptoms of depression. The score range is 0-63. The higher the score the more severe the depression. Scores above 41 are considered "extreme depression."

  2. Spatial Working Memory (SWM) [8 minutes]

    A measure of the key aspects of working memory and storage of information over short periods of time.

  3. Neuropsychological Outcomes: Motor Screen Tasks (MOT) [3 minutes]

    MOT provides a general indication that psychomotor function is intact enough to proceed with more sophisticated cognitive testing:

Secondary Outcome Measures

  1. Neuropsychological Outcomes: MOT Mean Latency, MOT Total Correct, and MOT Total Errors [10 minutes]

    This test is a general assessment of whether there are sensorimotor deficits or lack of comprehension. Outcome is measured by reaction time in milliseconds of the participant reaching out and touching the "X" correctly (in the middle of the X) on the tablet in response to the stimulus. The maximum score is 6000 milliseconds. The number of total correct touches and total errors in not touching correctly out of 10 are recorded. Ex: MOT mean latency = 927.9 ml +/- 131.43 ms; MOT Total Correct = 10; MOT Total Errors = 0.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Males and females over the age of 18 years

  • With or without symptoms of depression

  • Physically inactive or sedentary (less than 30 minutes per day)

  • Normal vision and no color blindness

  • No physical disorders such as walking with assistance

Exclusion Criteria:
  • Below the age of 18 years or over 65 years,

  • Women who are pregnant

  • Individuals who have been diagnosed with mental disorders

  • Individuals with leg injuries

  • Individuals with cardiac problems

  • Individuals with a history of asthma

  • Individuals with a body mass index over 30.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UTArlington Arlington Texas United States 76019

Sponsors and Collaborators

  • The University of Texas at Arlington

Investigators

  • Principal Investigator: Judy R Wilson, Ph.D., UTArlington

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Judy Wilson, Associate Professor, The University of Texas at Arlington
ClinicalTrials.gov Identifier:
NCT05973461
Other Study ID Numbers:
  • 2020-0376
First Posted:
Aug 2, 2023
Last Update Posted:
Aug 2, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 2, 2023